SPINDLE CELL RHABDOMYOSARCOMA
Clinical trials for SPINDLE CELL RHABDOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new SPINDLE CELL RHABDOMYOSARCOMA trials appear
Sign up with your email to follow new studies for SPINDLE CELL RHABDOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could adding temsirolimus boost chemo for childhood muscle cancer?
Disease control OngoingThis phase 3 trial tests whether adding the drug temsirolimus to standard chemotherapy helps children and young adults with intermediate-risk rhabdomyosarcoma, a type of muscle cancer. About 325 participants receive either standard chemo or standard chemo plus temsirolimus. The s…
Matched conditions: SPINDLE CELL RHABDOMYOSARCOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New drug cocktail shows promise against aggressive childhood cancer
Disease control OngoingThis study tests whether adding a drug called vinorelbine to standard chemotherapy can better control high-risk rhabdomyosarcoma, a rare and aggressive muscle cancer in children and young adults. About 118 participants will receive either the standard treatment or the new combina…
Matched conditions: SPINDLE CELL RHABDOMYOSARCOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC